Microbial profile and drug resistance of Candida strains isolated from the blood of children: An 11-year study

Mycoses

Volumn 52, Issue 2, 2009, Pages 149-153

  Małafiej, Eugeniusz ^a   Adamiec, Anna Ciebiada ^a   Tworzyańska, Urszula ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Antifungal susceptibility; Candida spp.; Candidaemia; Epidemiology

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCYTOSINE;

ARTICLE; BLOOD SAMPLING; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDEMIA; CHILD; DRUG SENSITIVITY; FUNGAL STRAIN; FUNGEMIA; FUNGUS ISOLATION; HOSPITAL PATIENT; HUMAN; INCIDENCE; MICROBIOLOGY; MYCOSIS; NONHUMAN; OBSERVATION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, FUNGAL; FUNGEMIA; HOSPITALIZATION; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; POLAND; PREVALENCE;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS;

EID: 59149104703     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01560.x     Document Type: Article

References (28)

1. Szymankiewicz M, Kowalewski J. Zakażenia wywoływane przez grzyby Candida. Czynniki predysponujǎce. Mikol Lek 2005 12 : 189 92.
2. Kołodziej T, Baran W, Nockowski P. Systemowe zakażenia grzybicze na oddziałach intensywnej opieki medycznej. Mikol Lek 2003 10 : 149 53.
3. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005 4 : 1232 9.
4. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a Tertiary Care Institution. Pediatrics 2005 116 : 61 67.
5. Chen S, Slavin M, Nguen Q et al. Active surveillance for candidemia, Australia. Emerg Infect Dis 2006 10 : 1508 16.
6. Sandven P, Bevanger L, Digranes A et al. Candidemia in Norway (1991 to 2003): results from a Nationwide Study. J Clin Microbiol 2006 44 : 1977 81.
7. Krcmery V, Laho L, Huttova M et al. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia. J Med Microbiol 2002 51 : 110 6.
8. Rani R, Mohapatra NP, Mehta G, Randhawa VS. Changing trends of Candida species in neonatal septicaemia in a tertiary North Indian hospital. Indian J Med Microbiol 2002 20 : 42 44.
9. Sarvikivi E, Lyytikäinen O, Soll DR et al. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol 2005 43 : 2729 35.
10. Cuenca-Estrella M, Rodriguez D, Almirante B et al. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. JAC 2005 55 : 194 9.
11. Chakrabarti A, Mohan B, Shrivastava SK, Marak R, Ghosh A, Ray P. Change in distribution and antifungal susceptibility of Candida species isolated from candidaemia cases in a tertiary care centre during 1996-2000. Indian J Med Res 2002 116 : 5 12.
12. Cybulski Z, Krzemińska-Jaśkowiak E, Grabiec A, Talaga Z. Porównanie lekowrażliwości szczepów C. glabarata, C. tropicalis, C. parapsilosis, C. krusei i C kefir izolowanych z różnych źródeł. Współczesna onkologia 2003 7 : 404 9.
13. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998 26 : 1086 8.
14. Krcmery V, Kovacicova G. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group. Diagn Microbiol Infect Dis 2000 36 : 7 11.
15. Citak S, Özcelik B, Cesur S, Abbasoǧlu U. In vitro susceptibility of Candida species isolated from blood cultures to some antifungal agents. Jpn J Inf Dis 2005 58 : 44 46.
16. Rós Ásmundsdóttir L, Erlendsdóttir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 2002 40 : 3489 92.
17. Hajjeh RA, Sofair AN, Harrison LH et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004 42 : 1519 27.
18. St-Germain G, Laverdiere M, Pelletier R et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 2001 39 : 949 53.
19. Sendid B, Cotteau A, François N et al. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links. BMC Infect Dis 2006 80 doi :.
20. Schelenz S, Gransden WR. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses 2003 46 : 390 6.
21. Nguyen MH, Peacock JE, Morris AJ et al. The changing face of candidaemia - emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996 100 : 617 23.
22. Almirante B, Rodríguez D, Cuenca-Estrella M et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006 44 : 1681 5.
23. Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994 38 : 1422 7.
24. Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. J Clin Microbiol 1998 36 : 1886 9.
25. Pfaller MA, Jones RN, Doern GV et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000 44 : 747 51.
26. Cuenca-Estrella M, Rodero L, Garcia-Effron G, Rodriguez-Tudela JL. Antifungal susceptibilities of Candida spp. isolated from blood in Spain and Argentina, 1996-1999. J Antimicrob Chemother 2002 49 : 981 7.
27. Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002 40 : 3551 7.
28. Tortorano AM, Biraghi E, Astolfi A et al. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 2002 51 : 297 304.